Avacta exploded higher, and I’m finding other strong-performing shares too

In this stock-picker’s market, Avacta isn’t the only opportunity. Here’s where I’m finding some decent share ideas right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

On 3 April, the Avacta (LSE: AVCT) share price stood close to 20p. Today, it’s near 182p. You don’t need me to tell you how holding the stock could have transformed your portfolio.

The biotechnology company’s share price exploded higher when it announced an agreement with Cytiva to develop a saliva-based rapid antigen test to indicate whether a person has the Covid-19 infection.

Then, on 20 May, Avacta revealed it had entered a “global, exclusive, direct-to-consumer sales and marketing” agreement for its Covid-19 antigen test with Medusa 19 Ltd.

A substantial market for the Avacta test

Avacta’s chief executive, Dr Alastair Smith, said in the recent update the potential size of the market for the firm’s saliva test is “substantial.” He reckons the demand will come from businesses for workforce screening as well as directly from consumers.

It seems like a no-brainer to expect these tests to fly off the shelves in the current pandemic. But it remains unclear how profitable sales will be. And the company has invested significant sums of money into getting the test off the ground. Meanwhile, the coronavirus will only run for so long. The R (reproduction) value of the virus has been falling, and the market for tests could vanish if a vaccine arrives.

If I’d been lucky enough to have been holding shares in Avacta through the recent rises, I’d take at least some of my money off the table now and possibly all of it. I reckon investing can be at its best if we aim to run to where the ball is going rather than where it is now. For me, that means looking at other opportunities today.

And I’ve been finding some strong-performing shares in the stock market recently. Luckily, many haven’t exploded up so far and as fast as Avacta. But the trends are up, driven by resilient underlying business performance.

A stock-picker’s market

I reckon it pays to be selective though. It’s true that lockdowns are easing and many businesses can soon resume trading, such as retailers. But a world with coronavirus will be different, and that looks set to lead to reduced revenue and profits for many companies. Meanwhile, there are some sectors with uncertain futures, such as the hospitality industry and travel.

However, other sectors are doing well, such as IT, computing, healthcare, food supplies and others. In many cases, business hasn’t been affected much by the crisis and has sometimes been enhanced by it.

Right now, I like the look of shares such as Avast, Beeks Financial Cloud, Codemasters, Faron Pharmaceuticals, Genus and Sage, to name but a few. But don’t buy the shares without first researching and analysing the underlying business though.

If you like what you’re seeing after doing your own research, I reckon you’ll find other attractive opportunities in the sectors I’ve mentioned. And promising shares in other sectors too. Good hunting!

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »